Transfemoral Aortic Valve Replacement With the Edwards SAPIEN and Edwards SAPIEN XT Prosthesis Using Exclusively Local Anesthesia and Fluoroscopic Guidance Feasibility and 30-Day Outcomes

被引:138
作者
Durand, Eric [1 ]
Borz, Bogdan [1 ]
Godin, Matthieu [1 ]
Tron, Christophe [1 ]
Litzler, Pierre-Yves [2 ]
Bessou, Jean-Paul [2 ]
Bejar, Karim [1 ]
Fraccaro, Chiara [1 ]
Sanchez-Giron, Carlos [1 ]
Dacher, Jean-Nicolas [3 ]
Bauer, Fabrice [1 ]
Cribier, Alain [1 ]
Eltchaninoff, Helene [1 ]
机构
[1] Univ Hosp Rouen, Hosp Charles Nicolle, INSERM, Dept Cardiol,U 1096, Rouen, France
[2] Univ Hosp Rouen, Hosp Charles Nicolle, INSERM, Dept Cardiac Surg,U 1096, Rouen, France
[3] Univ Hosp Rouen, Hosp Charles Nicolle, INSERM, Dept Radiol,U 1096, Rouen, France
关键词
anesthesia; aortic stenosis; TAVR; Valve Academic Research Consortium (VARC); IMPLANTATION; STENOSIS; EXPERIENCE;
D O I
10.1016/j.jcin.2012.01.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The authors report the feasibility and 30-day outcomes of transfemoral aortic valve replacement (TAVR), using the Edwards SAPIEN (Edwards Lifesciences, Irvine, California) and Edwards SAPIEN XT (Edwards Lifesciences) prosthesis, implanted using exclusively local anesthesia and fluoroscopic guidance. Background Transfemoral TAVR is often managed with general anesthesia. However, a simplified percutaneous approach using local anesthesia has become more popular because it offers multiple advantages in an elderly and fragile population. Methods Between May 2006 and January 2011, the authors prospectively evaluated 151 consecutive patients (logistic EuroSCORE: 22.8 +/- 11.8%) who underwent TAVR (SAPIEN: n = 78, SAPIEN XT: n = 73) using only local anesthesia and fluoroscopic guidance. The primary endpoint was a combination of all-cause mortality, major stroke, life-threatening bleeding, stage 3 acute kidney injury (AKI), periprocedural myocardial infarction (MI), major vascular complication, and repeat procedure for valve-related dysfunction at 30 days. Results Transarterial femoral approach was surgical in all SAPIEN procedures and percutaneous in 97.3% of SAPIEN XT, using the ProStar vascular closure device, and was well tolerated in all cases. Conversion to general anesthesia was required in 3.3% (SAPIEN cases) and was related to complications. Vasopressors were required in 5.5%. Procedural success was 95.4%. The combined-safety endpoint was reached in 15.9%, including overall mortality (6.6%), major stroke (2.0%), life-threatening bleeding (7.9%), stage 3 AKI (0.7%), periprocedural MI (1.3%), major vascular complication (7.9%), and repeat procedure for valve-related dysfunction (2.0%) at 30 days. A permanent pacemaker was required in 5.3%. Conclusions This single-center, prospective registry demonstrated the feasibility and safety of a simplified transfemoral TAVR performed using only local anesthesia and fluoroscopic guidance in high surgical risk patients with severe aortic stenosis. (J Am Coll Cardiol Intv 2012;5:461-7) (C) 2012 by the American College of Cardiology Foundation
引用
收藏
页码:461 / 467
页数:7
相关论文
共 13 条
[1]   Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis - First human case description [J].
Cribier, A ;
Eltchaninoff, H ;
Bash, A ;
Borenstein, N ;
Tron, C ;
Bauer, F ;
Derumeaux, G ;
Anselme, F ;
Laborde, F ;
Leon, MB .
CIRCULATION, 2002, 106 (24) :3006-3008
[2]   Treatment of calcific aortic stenosis with the percutaneous heart valve - Mid-term follow-up from the initial feasibility studies: The French experience [J].
Cribier, A ;
Eltchaninoff, H ;
Tron, C ;
Bauer, F ;
Agatiello, C ;
Nercolini, D ;
Tapiero, S ;
Litzler, PY ;
Bessou, JP ;
Babaliaros, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (06) :1214-1223
[3]   Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry [J].
Eltchaninoff, Helene ;
Prat, Alain ;
Gilard, Martine ;
Leguerrier, Alain ;
Blanchard, Didier ;
Fournial, Gerard ;
Iung, Bernard ;
Donzeau-Gouge, Patrick ;
Tribouilloy, Christophe ;
Debrux, Jean-Louis ;
Pavie, Alain ;
Gueret, Pascal .
EUROPEAN HEART JOURNAL, 2011, 32 (02) :191-197
[4]   Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines [J].
Gurvitch, Ronen ;
Toggweiler, Stefan ;
Willson, Alexander B. ;
Wijesinghe, Namal ;
Cheung, Anson ;
Wood, David A. ;
Ye, Jian ;
Webb, John G. .
EUROINTERVENTION, 2011, 7 (01) :41-48
[5]   One year follow-up of the multi-centre European PARTNER transcatheter heart valve study [J].
Lefevre, Thierry ;
Kappetein, Ari Pieter ;
Wolner, Ernst ;
Nataf, Patrick ;
Thomas, Martyn ;
Schaechinger, Volker ;
De Bruyne, Bernard ;
Eltchaninoff, Helene ;
Thielmann, Matthias ;
Himbert, Dominique ;
Romano, Mauro ;
Serruys, Patrick ;
Wimmer-Greinecker, Gerhard .
EUROPEAN HEART JOURNAL, 2011, 32 (02) :148-157
[6]   Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium [J].
Leon, Martin B. ;
Piazza, Nicolo ;
Nikolsky, Eugenia ;
Blackstone, Eugene H. ;
Cutlip, Donald E. ;
Kappetein, Arie Pieter ;
Krucoff, Mitchell W. ;
Mack, Michael ;
Mehran, Roxana ;
Miller, Craig ;
Morel, Marie-Angele ;
Petersen, John ;
Popma, Jeffrey J. ;
Takkenberg, Johanna J. M. ;
Vahanian, Alec ;
van Es, Gerrit-Anne ;
Vranckx, Pascal ;
Webb, John G. ;
Windecker, Stephan ;
Serruys, Patrick W. .
EUROPEAN HEART JOURNAL, 2011, 32 (02) :205-U144
[7]   Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. [J].
Leon, Martin B. ;
Smith, Craig R. ;
Mack, Michael ;
Miller, D. Craig ;
Moses, Jeffrey W. ;
Svensson, Lars G. ;
Tuzcu, E. Murat ;
Webb, John G. ;
Fontana, Gregory P. ;
Makkar, Raj R. ;
Brown, David L. ;
Block, Peter C. ;
Guyton, Robert A. ;
Pichard, Augusto D. ;
Bavaria, Joseph E. ;
Herrmann, Howard C. ;
Douglas, Pamela S. ;
Petersen, John L. ;
Akin, Jodi J. ;
Anderson, William N. ;
Wang, Duolao ;
Pocock, Stuart .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (17) :1597-1607
[8]   Transcatheter Aortic Valve Implantation for the Treatment of Severe Symptomatic Aortic Stenosis in Patients at Very High or Prohibitive Surgical Risk Acute and Late Outcomes of the Multicenter Canadian Experience [J].
Rodes-Cabau, Josep ;
Webb, John G. ;
Cheung, Anson ;
Ye, Jian ;
Dumont, Eric ;
Feindel, Christopher M. ;
Osten, Mark ;
Natarajan, Madhu K. ;
Velianou, James L. ;
Martucci, Giuseppe ;
DeVarennes, Benoit ;
Chisholm, Robert ;
Peterson, Mark D. ;
Lichtenstein, Samuel V. ;
Nietlispach, Fabian ;
Doyle, Daniel ;
DeLarochelliere, Robert ;
Teoh, Kevin ;
Chu, Victor ;
Dancea, Adrian ;
Lachapelle, Kevin ;
Cheema, Asim ;
Latter, David ;
Horlick, Eric .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (11) :1080-1090
[9]   Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients [J].
Smith, Craig R. ;
Leon, Martin B. ;
Mack, Michael J. ;
Miller, Craig ;
Moses, Jeffrey W. ;
Svensson, Lars G. ;
Tuzcu, E. Murat ;
Webb, John G. ;
Fontana, Gregory P. ;
Makkar, Raj R. ;
Williams, Mathew ;
Dewey, Todd ;
Kapadia, Samir ;
Babaliaros, Vasilis ;
Thourani, Vinod H. ;
Corso, Paul ;
Pichard, Augusto D. ;
Bavaria, Joseph E. ;
Herrmann, Howard C. ;
Akin, Jodi J. ;
Anderson, William N. ;
Wang, Duolao ;
Pocock, Stuart J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (23) :2187-2198
[10]   Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis [J].
Tamburino, Corrado ;
Capodanno, Davide ;
Ramondo, Angelo ;
Petronio, Anna Sonia ;
Ettori, Federica ;
Santoro, Gennaro ;
Klugmann, Silvio ;
Bedogni, Francesco ;
Maisano, Francesco ;
Marzocchi, Antonio ;
Poli, Arnaldo ;
Antoniucci, David ;
Napodano, Massimo ;
De Carlo, Marco ;
Fiorina, Claudia ;
Ussia, Gian Paolo .
CIRCULATION, 2011, 123 (03) :299-308